From: Survival after heart transplantation for non-metastatic primary cardiac sarcoma
Patients | Survival (mo) median (range), (cases) | Log-rank P value | |
---|---|---|---|
Neoadjuvant chemotherapy | Yes | No | |
All | 15 (2–84), (n–18) | 18 (2–112), (n = 27) | 0.210 |
Non-angiosarcoma | 36 (5–84), (n = 8) | 43 (2–112), (n = 22) | 0.462 |
Grade3 | 7 (5–37), (n = 6) | 15 (2–43), (n = 9) | 0.731 |
Adjuvent chemotherapy | Yes | No | |
All | 15 (5–36), (n = 11) | 36 (2–112), (n = 34) | 0.088 |
Non-angiosarcoma | 18 (18–36), (n = 2) | 37 (2–112), (n = 28) | 0.407 |
Grade3 | 10 (5–18), (n = 5) | 16 (2–43), (n = 10) | 0.169 |